Beat the heat with these cooling gadgets and wearables
As heat waves blast the world like a blow dryer on high, folks are reaching for anything that promises a little personal chill: portable mini fans, cooling neck wraps, high-tech vests and all kinds of heat-beating headwear.
Of course, cooling gear helps most when paired with basic and safe strategies against the heat: most importantly hydration, shade and rest. Stay out of extreme heat when possible, and know the signs of heat exhaustion or heat stroke.
Yet these wearable wonders and breezy gadgets can offer some relief. They might look quirky, but when the AC struggles and the sidewalk feels like a stovetop, they can start to seem like must-haves.
When you're at home
Indoors, stay comfy with cool-feel sheets (like those with a silky finish or lightweight fibers), bed fans (where a nozzle inserted into the bed linens pumps a flow of air around you), or a cooling pillow or chill pad, which are filled with a gel that can stay cool for hours. Sleep-product brands include Serta, Sealy, Casper, Pluto and Threshold.
The chill pads can work for your own bed and the pets' bed too. There are chillable full-size mattresses (Chilipad, 8Sleep and BedJet get good reviews from The Spruce) and smaller, simple pads (CoolCare and Sharper Image, among others).
Outdoor wearables
Clare Epstein, an employee safety expert with Vector Solutions in Tampa, Florida, works to reduce heat stress for at-risk employees in industries like construction, aviation and agriculture. She recommends wearables like cooling scarves and evaporative cooling vests.
'By soaking the fabric in cold water at the beginning of the day, the vest slowly cools, and keeps the wearer cool,' she says.
Clothes made of 'phase change materials,' or PCMs, contain gel capsules or pads that can help moderate body temperatures. Uline.com advertises a vest that stays under 60 degrees for a few hours, and AlphaCool offers a neck tube that performs similarly. Another feature of the tube, which is made of a polymer material, is that it doesn't get overly chilled, so it's safe for kids to use.
Also for kids, there's a line of plush toys from Warmies that includes little critters of the farmyard, ocean, forest and safari that can be popped in the freezer before a trip to the park or playground.
Wearable items that incorporate small fans or thermoelectric coolers are also good, Epstein says. And there are vests with tubed reservoirs you can fill with water or electrolytes so you can sip as you go.
'These encourage people to take more water breaks, and stay hydrated,' says Epstein.
The wearables range is extensive. Along with cooling buffs, headbands, wristbands, socks and scarves, there are cooling brimmed hats and ball caps. Brands include Mission, Ergodyne, and Sunday Afternoon.
If you'd prefer a refreshing breeze, USB-chargeable handheld or wearable fans might do the job.
Chill advice
Lynn Campbell, co-founder of 10Adventures travel company in Calgary, Alberta, takes a lot of strenuous hiking and cycling trips with her husband, Richard. They've developed some easy hacks for hot days.
'We'll wake up early, so we're done by 10 or 11 a.m., or if we're out on the trails, split the day in two, so we rest by water or in the shade over the hottest part' of the day, she says.
Wear light colors and thin, breathable fabrics.
And bring an umbrella. 'This is a game-changer,' Campbell says. 'Now we always pack ultralight, compact ones; they're incredible.'
Also, pour cool water on your head and back. 'We freeze a few bottles of water so we can pour ice water on us to cool down,' Campbell says. 'Putting the bottles under the armpits, in the groin, or on the back of the neck can effectively cool a person down.'
And Annita Katee, a contributing writer for Apartment Therapy, has another way to prep your bed on hot nights:
Wednesdays
Columnist Jen Zoratti looks at what's next in arts, life and pop culture.
'Pop your sheets into the freezer at least two hours before bedtime, then pull them out right before you hit the sack,' she wrote in a recent post. She folds hers into a zipped plastic bag, flattens it, then sets it on a freezer shelf between ice packs.
'The result? A delightfully cool bed that feels like a refreshing oasis against the heat.'
___
New York-based writer Kim Cook covers design and decor topics regularly for The AP. Follow her on Instagram at @kimcookhome.
For more AP Lifestyles stories, go to https://apnews.com/lifestyle
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
a day ago
- Cision Canada
Roche Canada announces Polivy® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma is now Publicly Reimbursed in Québec Français
This marks the first provincial listing of Polivy as a first-line treatment for DLBCL in Canada, highlighting Roche's ongoing commitment to meeting the diverse needs of healthcare systems and patients affected by lymphoma. MISSISSAUGA, ON, July 22, 2025 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that Polivy® (polatuzumab vedotin for injection) in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients with previously untreated large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (NOS), high grade B-cell lymphoma, Epstein-Barr virus-positive (EBV+) DLBCL NOS, and T-cell/histiocyte rich LBCL, is now publicly funded in Québec. 1 Roche Canada is fully committed to continuing to work with the other provincial and territorial jurisdictions to make Polivy available to patients as soon as possible through all public drug plans. Lymphoma refers to a group of blood cancers that develop in the lymphatic system. The lymphatic system works with other components of the immune system to help the body combat infections and disease. 3 There are two general categories of the different types of lymphoma: Hodgkin and non-Hodgkin lymphoma (NHL), with NHL being more common. 4 Diffuse large B-cell lymphoma (DLBCL) is a common, fast-growing and very aggressive type of non-Hodgkin lymphoma (NHL). 5 It was estimated that in 2024, 11,700 Canadians were diagnosed with NHL. 2 Despite generally positive responses to initial treatments, up to 40% of patients will experience relapse or refractory disease. 6 By effectively managing the disease from the outset, there could be a substantial reduction in the need for subsequent treatments and the associated patient and societal burden. Polivy received the first marketing authorization in Canada on July 9, 2020 from Health Canada, and on July 2, 2025, Québec approved it for public reimbursement for first-line treatment of DLBCL. 3,7 This represents a much-needed advance in treatment options as Polivy offers hope to first-line DLBCL patients by reducing the risk of disease progression, relapse, or death by 27% compared to the current standard of care. 1 With the availability of Polivy for newly diagnosed patients with DLBCL in Québec, Roche is continuing its commitment to develop innovative therapies for those affected by lymphoma. We are proud to have worked closely with key organizations in our Canadian healthcare systems to move Polivy from regulatory approval through to public access, and this work continues with the other provinces and territories. About Polivy® (polatuzumab vedotin for injection) 1 Polatuzumab vedotin is a CD79b-targeted antibody-drug conjugate that preferentially delivers an anti-mitotic agent (monomethyl auristatin E, or MMAE) to B-cells, which results in the killing of malignant B-cells. The monoclonal antibody binds to CD79b, a cell surface component of the B-cell receptor. CD79b expression is restricted to normal cells within the B cell lineage (with the exception of plasma cells) and malignant B-cells; it is expressed in >95% of DLBCL. Upon binding CD79b, polatuzumab vedotin is rapidly internalized, aiding in the delivery of MMAE intracellularly. MMAE then works to kill dividing cells by inhibiting cell division and inducing apoptosis. About Diffuse Large B-cell Lymphoma (DLBCL) Lymphoma is the name for a group of blood cancers that develop in the lymphatic system and occur in two main types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). In particular, diffuse large B-cell lymphoma (DLBCL) is an aggressive (fast-growing) blood cancer and the most common form of NHL. 5 About Roche in hematology Roche has been developing medicines for people with malignant and non-malignant blood diseases for more than 25 years; our experience and knowledge in this therapeutic area runs deep. Today, we are investing more than ever in our effort to bring innovative treatment options to patients across a wide range of haematologic diseases. About Roche Canada At Roche Canada, patients and science are at the heart of everything we do. Our passion for science and our commitment to relentlessly pursuing the impossible for patients have made us one of the world's leading pharmaceutical, in-vitro diagnostics, and diabetes care management companies. With our combined strength in diagnostics and pharmaceuticals, we're driving healthcare forward, while ensuring we deliver meaningful benefits for patients and a sustainable healthcare system. Because we're committed to making quality healthcare accessible to everyone. And we're adding our expertise in new areas, such as artificial intelligence, real world data collection and analysis and collaborating with many different sectors and industries. Having the courage to reinvent ourselves and question the status quo is what patients and the healthcare system expect from Roche - and our commitment is as strong today as it was on the first day of our Canadian journey in 1931. Today, Roche Canada employs almost 2,000 people across the country through its Pharmaceuticals division in Mississauga, Ontario as well as its Diagnostics and Diabetes Care divisions in Laval, Québec. SOURCE Hoffmann-La Roche Limited (Roche Canada)
Toronto Sun
6 days ago
- Toronto Sun
World-first IVF trial reduces risk of babies inheriting diseases
Justice Department fires Maurene Comey, prosecutor on Epstein case and daughter of ex-FBI director Stampede bartender vows 'never' to do it again, citing abusive crowds and marathon shifts Nude photo leak meant to be 'distraction' from political goals, McGregor says MANDEL: Mentally ill man with history of stabbing strangers convicted of murder World-first IVF trial reduces risk of babies inheriting diseases Photo by PHILIPPE HUGUEN / AFP/File Article content Paris (AFP) — Eight healthy babies have been born in the UK using a new IVF technique that successfully reduced their risk of inheriting genetic diseases from their mothers, the results of a world-first trial said Wednesday. Advertisement 2 Story continues below This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account or Sign in without password View more offers Article content The findings were hailed as a breakthrough which raises hopes that women with mutations in their mitochondrial DNA could one day have children without passing debilitating or deadly diseases on to the children. Article content tap here to see other videos from our team. Try refreshing your browser, or World-first IVF trial reduces risk of babies inheriting diseases Back to video tap here to see other videos from our team. Try refreshing your browser, or Play Video Article content One out of every 5,000 births is affected by mitochondrial diseases, which cannot be treated, and include symptoms such as impaired vision, diabetes and muscle wasting. In 2015, Britain became the first country to approve an in-vitro fertilization (IVF) technique that uses a small amount of healthy mitochondrial DNA from the egg of a donor — along with the mother's egg and father's sperm. Some have called the result of this process 'three-parent babies', though researchers have pushed back at this term because only roughly 0.1 percent of the newborn's DNA comes from the donor. Your Midday Sun Your noon-hour look at what's happening in Toronto and beyond. There was an error, please provide a valid email address. Sign Up By signing up you consent to receive the above newsletter from Postmedia Network Inc. Thanks for signing up! A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Your Midday Sun will soon be in your inbox. Please try again Article content Advertisement 3 Story continues below This advertisement has not loaded yet, but your article continues below. Article content The results of the much-awaited UK trial were published in several papers in the New England Journal of Medicine. 'Important reproductive option' Out of 22 women to undergo the treatment at the Newcastle Fertility Centre in northeast England, eight babies were born. The four boys and four girls now range from under six months to over two years old. The amount of mutated mitochondrial DNA — which causes disease — was reduced by 95-100 percent in six of the babies, according to the research. For the other two newborns, the amount fell by 77-88 percent, which is below the range that causes disease. This indicates the technique was 'effective in reducing transmission' of diseases between mother and child, one of the studies said. Advertisement 4 Story continues below This advertisement has not loaded yet, but your article continues below. Article content The eight children are currently healthy, though one had a disturbance of their heart's rhythm which was successfully treated, the researchers said. Their health will be followed up over the coming years to see if problems arise. Nils-Goran Larsson, a Swedish reproductive expert not involved in the research, hailed the 'breakthrough'. The new technique offers a 'very important reproductive option' for families affected by 'devastating' mitochondrial diseases, he added. Ethical review Mitochondrial donation remains controversial and has not been approved in many countries, including the United States and France. Religious leaders have opposed the procedure because it involves the destruction of human embryos. Other opponents have expressed fears it could pave the way for genetically engineered 'designer babies'. Advertisement 5 Story continues below This advertisement has not loaded yet, but your article continues below. Article content An ethical review carried out by the UK's independent Nuffield Council on Bioethics was 'instrumental' in conducting the new research, the council's director Danielle Hamm said Wednesday. Peter Thompson, head of the UK's Human Fertilization and Embryology Authority which approved the procedure, said only people with a 'very high risk' of passing on a mitochondrial disease would be eligible for the treatment. Ethical concerns have also been raised over the use of mitochondrial donation for infertility in Greece and Ukraine. French mitochondrial disease specialist Julie Stefann told AFP that 'it is a question of the risk-benefit ratio: for a mitochondrial disease, the benefit is obvious'. 'In the context of infertility, it has not been proven,' she added. Oxford University reproductive genetics expert Dagan Wells observed that 'some scientists will be a little disappointed that so much time and effort has, so far, only led to the birth of eight children'. Among the children being closely monitored are three that showed some signs of what is known as 'reversal', which is still little understood. It is 'a phenomenon where the therapy initially succeeds in producing an embryo with very few defective mitochondria, but by the time the child is born the proportion of abnormal mitochondria in its cells has significantly increased,' he explained. Article content Share this article in your social network Read Next
CTV News
12-07-2025
- CTV News
Beat the heat with these cooling gadgets and wearables
This image released by Warmies shows plush animal toys that can be popped in the freezer to provide cooling comfort. (Warmies via AP) You can only sit in front of the fridge with the door open for so long. As heat waves blast the world like a blow dryer on high, folks are reaching for anything that promises a little personal chill: portable mini fans, cooling neck wraps, high-tech vests and all kinds of heat-beating headwear. Of course, cooling gear helps most when paired with basic and safe strategies against the heat: most importantly hydration, shade and rest. Stay out of extreme heat when possible, and know the signs of heat exhaustion or heat stroke. Yet these wearable wonders and breezy gadgets can offer some relief. They might look quirky, but when the AC struggles and the sidewalk feels like a stovetop, they can start to seem like must-haves. When you're at home Indoors, stay comfy with cool-feel sheets (like those with a silky finish or lightweight fibers), bed fans (where a nozzle inserted into the bed linens pumps a flow of air around you), or a cooling pillow or chill pad, which are filled with a gel that can stay cool for hours. Sleep-product brands include Serta, Sealy, Casper, Pluto and Threshold. The chill pads can work for your own bed and the pets' bed too. There are chillable full-size mattresses (Chilipad, 8Sleep and BedJet get good reviews from The Spruce) and smaller, simple pads (CoolCare and Sharper Image, among others). Outdoor wearables Clare Epstein, an employee safety expert with Vector Solutions in Tampa, Florida, works to reduce heat stress for at-risk employees in industries like construction, aviation and agriculture. She recommends wearables like cooling scarves and evaporative cooling vests. 'By soaking the fabric in cold water at the beginning of the day, the vest slowly cools, and keeps the wearer cool,' she says. Clothes made of 'phase change materials,' or PCMs, contain gel capsules or pads that can help moderate body temperatures. advertises a vest that stays under 60 degrees for a few hours, and AlphaCool offers a neck tube that performs similarly. Another feature of the tube, which is made of a polymer material, is that it doesn't get overly chilled, so it's safe for kids to use. Also for kids, there's a line of plush toys from Warmies that includes little critters of the farmyard, ocean, forest and safari that can be popped in the freezer before a trip to the park or playground. Wearable items that incorporate small fans or thermoelectric coolers are also good, Epstein says. And there are vests with tubed reservoirs you can fill with water or electrolytes so you can sip as you go. 'These encourage people to take more water breaks, and stay hydrated,' says Epstein. The wearables range is extensive. Along with cooling buffs, headbands, wristbands, socks and scarves, there are cooling brimmed hats and ball caps. Brands include Mission, Ergodyne, and Sunday Afternoon. If you'd prefer a refreshing breeze, USB-chargeable handheld or wearable fans might do the job. The Campbell family of Calgary This undated photo shows the Campbell family, wearing sun protection shirts and hats, posing for a photo during a hike in the Rocky Mountains near their Calgary, Alberta home, (Lynn Campbell via AP) (Photo: AP/Campbell family) Chill advice Lynn Campbell, co-founder of 10Adventures travel company in Calgary, Alberta, takes a lot of strenuous hiking and cycling trips with her husband, Richard. They've developed some easy hacks for hot days. 'We'll wake up early, so we're done by 10 or 11 a.m., or if we're out on the trails, split the day in two, so we rest by water or in the shade over the hottest part' of the day, she says. Wear light colors and thin, breathable fabrics. And bring an umbrella. 'This is a game-changer,' Campbell says. 'Now we always pack ultralight, compact ones; they're incredible.' Also, pour cool water on your head and back. 'We freeze a few bottles of water so we can pour ice water on us to cool down,' Campbell says. 'Putting the bottles under the armpits, in the groin, or on the back of the neck can effectively cool a person down.' And Annita Katee, a contributing writer for Apartment Therapy, has another way to prep your bed on hot nights: 'Pop your sheets into the freezer at least two hours before bedtime, then pull them out right before you hit the sack,' she wrote in a recent post. She folds hers into a zipped plastic bag, flattens it, then sets it on a freezer shelf between ice packs. 'The result? A delightfully cool bed that feels like a refreshing oasis against the heat.' ___ New York-based writer Kim Cook covers design and decor topics regularly for The AP. Follow her on Instagram at @kimcookhome.
